Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.
about
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients.Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product.
P2860
Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@ast
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@en
type
label
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@ast
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@en
prefLabel
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@ast
Trelagliptin (SYR-472, Zafatek ...... via a Non-Covalent Mechanism.
@en
P2093
P2860
P1433
P1476
Trelagliptin (SYR-472, Zafatek ...... ) via a Non-Covalent Mechanism
@en
P2093
Akiyoshi Tani
Andy Jennings
Emiko Koumura
Hikaru Ueno
Hiroki Sano
Koji Takeuchi
Lihong Shi
Nobuhiro Nishigaki
Ruhi Kamran
Takuo Kosaka
P2860
P304
P356
10.1371/JOURNAL.PONE.0157509
P407
P577
2016-06-21T00:00:00Z